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based on WHO anatomical therapeutic chemical (ATC) classiﬁca-
tion system and Deﬁned daily doses (DDDs) per 1000 patients
were calculated. Type and class of prescribed antibiotics and adher-
ence to the generic name prescribing and National list of essential
medicines of India (NLEMI) were analyzed.
Results: Overall, 20303 patients were admitted in the medicine
departments of twohospitals, ofwhich 66%were prescribed antibi-
otics. Malaria or viral fever was diagnosed in 693 patients in the TH
and 1177 in the NTH. Of these, 82% patients at the TH and 71%
at the NTH (71%, p<0.001) were prescribed antibiotics. Prescrip-
tions made at the TH show more adherence both towards the use
of generic namesand theNLEMI, comparedwith theNTH (p<0.001).
Most commonlyprescribed antibiotic classes at the THwereﬂuoro-
quinolones (48%) and third generation cephalosporins (21%) and at
theNTHwere thirdgenerationcephalosporins (47%), andﬁxeddose
combinations (19%). The most prescribed antibiotic substances at
the THwas ciproﬂoxacin (1940DDD/1000patients), and at theNTH
was ceftriaxone (1052 DDD/1000 patients).
Conclusion: Frequent and unnecessary antibiotic prescribing
practices at both hospitals were observed. Signiﬁcantly high per-
centage of patients in non-bacterial infection groups i.e. malaria
and viral fever, were prescribed antibiotics which is a point of
concern. An urgent need is felt to develop and implement rele-
vant antibiotic stewardship program to rationalize the antibiotic
prescribing in the settings.
http://dx.doi.org/10.1016/j.ijid.2016.02.308
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Background: Background: HIV/AIDS has threatened an enor-
mous worldwide challenge on the survival of mankind. Antiretro-
viral therapy (ART) for HIV is increasingly being introduced and
utilized in diverse areas of theworld.However, little research exists
on adherence to ART in different cultural settings, particularly in
developing countries such as Nepal. This study aimed to determine
adherence to ART and identify associated factors with adherence
among people with HIV/AIDS and receiving ART/ARV therapy.
Methods & Materials: Methods and materials: In this cross
sectional study total of 300 HIV positive subjects were interviewed
using semi-structured questionnaire. Study subjects were ran-
domly selected fromdifferent HIV clinics of three districts; Sunsari,
Morang and Jhapa of EasternNepal. Informed&understoodwritten
consentwas taken and coﬁdencialitywasmentained throughout of
the study.
Results: Results: The median age for patients was 34 yr. Maju-
rity of the respondents were using a non protease inhibitor (PI)
treatment regimen (98%). Mean 4-day adherence was 92%. Adher-
ence was lower over longer periods of recall; Twenty percent
reportedmissed does over the past 7 days; 33% reported evermiss-
ing a full day’s medications and 16% had a treatment interruption
of more than 7-days at least once. On univariate analysis less than
university education, being unemployed, obtaining free treatment,
severe depression, hospitalization >2 times, having moderate to
severe side-effects and taking 4 ormoremedicineswere associated
with lower adherence (<90%). However, only obtaining free treat-
ment (adjusted OR, 4.05, 95% CI 1.42-11.54, P=0.009) and severe
depression (adjusted OR 4.48, 95% CI 1.64-12.27, P=0.003) were
associated with lower adherence in multivariate analysis.
Conclusion: Conclusion: Although the overall adherence was
high, lower levels of adherence were documented among poor
patients receiving free ARV/ART. Provision of free treatment of ART
andsideeffectmanagement shouldmakeavailableup tounreached
poor people of community.
http://dx.doi.org/10.1016/j.ijid.2016.02.309
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Background: The uses of medicinal plants for treatment of
various infections in traditional communities have been an age-
long practice. This provides the rationale to study medicinal plant
extracts as a possible source of alternative therapy against infec-
tions.
Methods & Materials: The current study was undertaken
to evaluate the phytochemical and antimicrobial properties of
Aspilia africana. The antimicrobial activity andminimum inhibitory
concentration (MIC) of the extracts of Aspilia Africana were eval-
uated against eight organisms-Staphylococcus aureus, Escherichia
coli, Pseudomonas aureginosa, Salmonella typhi, Candida albicans,
Aspergillus niger, Penicillum spp and Fusarium spp. The ethanolic
and aqueous extracts were obtained by standard methods. Antimi-
crobial activity was conducted using a modiﬁed agar well diffusion
method.
Results: The phytochemical screening and analysis carried out
in this study showed that the plant extracts contains alkaloids
(6.35%), saponins (3.26%), ﬂavonoids (2.01%), tannins(0.88%) and
phenols (0.11%). The result showed that ethanolic extract of Aspilia
africana exerted antimicrobial effect on the test organisms at
25mg/ml, 50mg/ml and 100mg/ml concentrations, while the hot
aqueous extract exerted antimicrobial effect at 100mg/ml only on
Staphylococcus aureus and Pseudomonas aureginosa. The ethanolic
extract of Aspilia Africana showed the highest antimicrobial activ-
ity with diameter of zone of inhibition of 3.35mm to 17.9mm
at 100mg/concentration. The minimum inhibitory concentration
(MIC) of the ethanolic extracts was at a concentration of 25mg/ml.
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Conclusion: The antimicrobial activity of the extract could be
enhanced if the components are puriﬁed. This plant therefore holds a
promising potential source of new drug for treating infections caused
by these clinical pathogens.
http://dx.doi.org/10.1016/j.ijid.2016.02.310
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Background: Fast breathing pneumonia or isolated tachypnea
in children, is presumed to be mostly viral in origin. WHO guide-
lines recommend 3 days of amoxicillin therapy for all childrenwith
fast breathing pneumonia in resource limited settings. The recom-
mendations have arisen largely out of hospital studies where the
spectrum of disease is more severe. High quality clinical trial evi-
dence to challenge or support the continued use of antibiotics, in
low-resource community settings is lacking.
Methods & Materials: A community based randomized double
blinded placebo-controlled non-inferiority trial is being conducted
at primary healthcare centres located in two low income squat-
ter settlements of Karachi, Pakistan. Children aged 2-59 months
with WHO deﬁned fast breathing pneumonia are included if they
have no danger signs, SaO2 ≥ 90% on pulse oximetry, absence
of use of antibiotics in last 48 hours, no bulging fontanels, pedal
edema, asthma, tuberculosis or congenital heart disease. Children
are being randomized to receive either 3 days of oral Amoxicillin
(standard) or matching placebo (intervention), with 1215 children
to be enrolled in each arm. Primary outcome is the difference in
treatment failure rates between the two groups, deﬁned as a new
clinical sign based on preset deﬁnitions indicating illness progres-
sion or mortality on day 0, 1, 2 or 3 of therapy.
Results: FromSeptember 2014 till August 2015, a total of 19,363
children were triaged. Among these, 11,161 (58%) presented with
cough or difﬁculty in breathing. 2,216 (20%) met the inclusion cri-
teria i.e. have history of cough for less than two weeks and have
tachypnea. About 40% of all fast breathing under 5 years occurs
in babies 2-11 months of age. Of these children with fast breath-
ing, 1056 children have been enrolled so far. The overall treatment
failure is 3% and no mortality.
Conclusion: The overall rates of treatment failure and relapse in
fast breathing pneumonia are low. The trial results will strengthen
the evidence to support or refute the use of antibiotics in WHO-
IMCI management of pneumonia. Findings will be generalizable
to resource limited settings with low HIV and malaria prevalence
andHib andPneumococcal vaccines in their national immunization
plan.
http://dx.doi.org/10.1016/j.ijid.2016.02.311
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Background: A renewed interest in the usage of polymyxins has
been observed, as they are the only treatment option left for mul-
tidrug resistant (MDR) and pan-drug resistant (PDR) pathogens like
Acinetobacter baumannii. However, knowledge of the pharmacoki-
netics (PK) and pharmacodynamics (PD) of polymyxins is limited,
resulting in inappropriate dosing, potential toxicity and develop-
ment of resistance. We planned to conduct this prospective PK-PD
studyof intravenously administered colistin in Indianpatientswith
MDR Gram-negative infections to estimate the levels of both total
and free colistin.
Methods & Materials: This was a prospective PK-PD study
of intravenously administered colistin in ten patients with MDR
Gram-negative infections. The recommended systemic dose of pro-
drug, colistin methanesulfonate (CMS) was given as 4–6 mg/kg per
day as a short-term infusion (for 1 hour) or 1–2 million IU/day
in three divided doses (12,500 IU/1mg of CMS). Highly sensitive
UHPLC-MS/SRM method was developed and validated to quantify
free and total colistin from human sera. Correlation between the
predictor variables like AUC/MIC ratiowas performed usingGraph-
PadInstat ver. 6 for Mac version 10.10.1 (GraphPad Software, San
Diego CA: www.graphpad.com).
Results: The area under the plasma concentration-versus-time
curve over 8 hrs (AUC0 – 8) for free and total colistin ranged after 5th
dose from28.2 to126mg*Y¨h/liter and25.8 to404.9mg*Y¨h/l respec-
tively. All the follow up blood cultures were sterile and majority of
the patients survived.
AUC (0-8) for free and total colistin after 1st(A, C) and 5th
doses (B,D) in 10 patients
Conclusion: This is the ﬁrst Indian study where free colistin
levels were also estimated. The desired colistin levels to be effec-
tive without giving the loading dose were achieved in these Indian
